The distribution of cartilage oligomeric matrix protein (COMP) in tendon and its variation with tendon site, age and load

Matrix Biology

Volumn 16, Issue 5, 1997, Pages 255-271

  Smith, R K W ^a   Zunino, L ^b   Webbon, P M ^a   Heinegard D ^b  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Cartilage oligomeric matrix protein; Extracellular matrix; Tendon

Indexed keywords

MATRIX PROTEIN; POLYCLONAL ANTIBODY;

AGE; ANIMAL TISSUE; ARTICLE; CARTILAGE; CATTLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROSARCOMA; FLEXOR TENDON; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORSE; IMMUNOBLOTTING; ION EXCHANGE CHROMATOGRAPHY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RABBIT; SKIN SCAR;

ANIMALIA; BOS TAURUS; BOVINAE; EQUIDAE; EQUUS CABALLUS; ORYCTOLAGUS CUNICULUS;

EID: 0031282595     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0945-053X(97)90014-7     Document Type: Article

References (50)

1. Banes A.J., Tsuzaki M., Yamamoto J., Fischer T., Brigman B., Brown T., Miller L. Mechanoreception at the cellular level: the detection, interpretation, and diversity of responses to mechanical stimuli. Biochem. Cell Biol. 73:1995;349-365.
2. Barry F.P., Gaw J.U., Boynton R.E., Neame P.J. A keratan sulphate binding protein from cartilage. Transactions of the 41st Annual Meeting of the Orthopaedic Research Society, Orlando, Florida. 20:1995;145.
3. Briggs M.D., Hoffman S.M.G., King L.M., Olsen A.S., Mohrenweiser H., Leroy J.G., Mortier G.R., Rimoin D.L., Lachman R.S., Gaines E.S., Cekleniak J.A., Knowlton R.G., Cohn D.H. Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene. Nat. Genet. 10:1995;330-336.
4. Daniel J.C., Mills D.K. Proteoglycan synthesis by cells cultured from regions of rabbit flexor tendon. Connect. Tissue Res. 17:1988;215-230.
5. DiCesare P., Hauser N., Lehman D., Pasumarti S., Paulsson M. Cartilage oligomeric matrix protein (COMP) is an abundant component of tendon. FEBS Lett. 354:1994a;237-240.
6. DiCesare P.E., Mörgelin M., Carlson C.S., Pasumarti S., Paulsson M. Cartilage oligomeric matrix protein (COMP): isolation and characterization from human articular cartilage. J. Orthop. Res. 13:1995;422-428.
7. DiCesare P.E., Mörgelin M., Mann K., Paulsson M. Cartilage oligomeric matrix protein and thrombospondin 1. Purification from articular cartilage, electron microscopic structure, and chondrocyte binding. Eur. J. Biochem. 223:1994b;927-937.
8. DiCesare P.E., Mörgelin M., Paulsson M. Purification, electron microscopic structure, and cell binding capacity of native cartilage oligomeric protein and thrombospondin from bovine articular cartilage. Transactions of the 39th Annual Meeting of the Orthopaedic Research Society, San Francisco, California. 18:1993;71.
9. Dixit V.M., Grant G.A., Santoro S.A., Frazier W.A. Isolation and characterization of a heparin-binding domain from the amino terminus of platelet thrombospondin. J. Biol. Chem. 259:1984;10100-10105.
10. Efimov V.P., Lustig A., Engel J. The thrombospondin-like chains of cartilage oligomeric matrix protein are assembled by a five-stranded a-helical bundle between residues 20 and 83. FEBS Lett. 341:1994;54-58.
11. Ekman S., Heinegård D. Immunohistochemical localization of matrix proteins in the femoral joint cartilage of growing commercial pigs. Vet. Pathol. 29:1992;514-520.
12. Evanko S.P., Vogel K.G. Ultrastructure and proteoglycan composition in the developing fibrocartilagenous region of bovine tendon. Matrix. 10:1990;420-436.
13. Forslind K., Eberhardt K., Jonsson A., Saxne T. Increased serum concentrations of cartilage oligomeric matrix protein. A prognostic marker in early rheumatoid arthritis. Br. J. Rheum. 31:1992;593-598.
14. Frank C., Woo S., Andriacchi T., Brand R., Oakes B., Dahners L., DeHaven K., Lewis J., Sabiston P. Normal ligament: structure, function, and composition. Woo S.L.-Y., Buckwalter J.A. Injury and Repair of Musculoskeletal Soft Tissues. 1987;45-101 Am. Acad. Orthop. Surg. Park Ridge, Illinois.
15. Hauser N., Geiss J., Neidhart M., Paulsson M., Häuselmann H.J. Distribution of CMP and COMP in human cartilage. Acta Orthop. Scand. 66:(Suppl. 266):1995a;72-73.
16. Hauser N., Paulsson M., Kale A.A., DiCesare P.E. Tendon extracellular matrix contains pentameric thrombospondin-4 (TSP-4). FEBS Lett. 368:1995b;307-310.
17. Hecht J. Mutations in thrombospondin 5/COMP in pseudoachondroplasia. The Thrombospondin Gene Family and its Functional Relatives: Tenascins, Osteopontin, and SPARC. 1996;. Seattle, Washington.
18. Hecht J.T., Nelson L.D., Crowder E., Wang Y., Elder F.F.B., Harrison W.R., Francomano C.A., Prange C.K., Lennon G.C., Deere M., Lawler J. Mutations in exon 17B of cartilage oligomeric matrix protein (COMP) cause pseudoachondroplasia. Nat. Genet. 10:1995;325-329.
19. Hedbom F., Antonsson P., Hjerpes A., Aeschlimann D., Paulsson M., Rosa-Pimental E., Sommarin Y., Wendel M., Oldberg Å., Heinegård D. Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage. J. Biol. Chem. 267:1992;6132-6136.
20. Jones A.J. Normal and diseased equine digital flexor tendon: blood flow, biochemical, and serological studies. Ph.D. thesis, London. 1993.
21. Jones K. Pseudoachondroplastic spondyloepiphyseal dysplasia (SED). Smith's Recognizable Patterns of Human Malformation. 4th ed. 1988;306-307 W.B. Saunders, Philadelphia.
22. Koob T.J., Vogel K.G. Site-related variations in glycosaminoglycan content and swelling properties of bovine flexor tendon. J. Orthop. Res. 5:1987;414-424.
23. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
24. Lohmander L.S., Saxne T., Heinegård D. Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis. Ann. Rheum. Dis. 53:1994;8-13.
25. Malashkevich V.N., Kammerer R.A., Efimov V.P., Schulthess T., Engel J. The crystal structure of a five-stranded coiled coil in COMP: a prototype ion channel? Science. 274:1996;761-764.
26. Månsson B., Carey D., Alini M., Ionescu M., Rosenberg L.C., Poole A.R., Heinegård D., Saxne T. Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism. J. Clin. Invest. 95:1995;1071-1077.
27. Mörgelin M., Heinegård D., Engel J., Paulsson M. Electron microscopy of native cartilage oligomeric matrix protein purified from the Swarm rat chondrosarcoma reveals a five-armed structure. J. Biol. Chem. 267:1992;6137-6141.
28. Newton G., Weremowicz S., Morton C.C., Copeland N.G., Gilbert D.J., Jenkins N.A., Lawler J. Characterization of human and mouse cartilage oligomeric matrix protein. Genomics. 24:1994;435-439.
29. Oldberg Å., Antonsson P., Lindblom K., Heinegård D. COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins. J. Biol. Chem. 267:1992;22346-22350.
30. Paulsson M., Heinegård D. Radioimmunoassay of the 148-kilodalton cartilage protein. Distribution of the protein among bovine tissues. Biochem. J. 207:1982;207-213.
31. Petersson I.F., Sandqvist L., Svensson B., Saxne T. Cartilage markers in synovial fluid in symptomatic knee osteoarthritis. Ann. Rheum. Dis. 56:1997;64-67.
32. Qabar A., Derick L., Lawler J., Dixit V. Thrombospondin 3 is a pentameric molecule held together by interchain disulfide linkage involving two cysteine residues. J. Biol. Chem. 270:1995;12725-12729.
33. Robbins J.R., Vogel K.G. Aggrecan and collagen mRNA expression in the tensional and compressed regions of bovine tendon. Transactions of the 39th Annual Meeting of the Orthopaedic Research Society, San Francisco, California. 18:1993;660.
34. Rosenfeld G., Capdevielle J., Guillemot J.-C., Ferrara P. In-gel digestion of proteins for internal sequence analysis after one- or two-dimensional gel electrophoresis. Anal. Biochem. 203:1992;173-179.
35. Saxne T., Glennås A., Kvien T.K., Melby K., Heinegård D. Release of cartilage macromolecules into the synovial fluid in patients with acute and prolonged phases of reactive arthritis. Arthritis Rheum. 36:1993;20-25.
36. Saxne T., Heinegård D. Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood. Br. J. Rheum. 31:1992;583-591.
37. Sharif M., Saxne T., Shepstone L., Kirwan J.R., Elson C.J., Heinegård D., Dieppe P.A. Relationship between serum cartilage oligomeric matrix protein levels and disease progression in osteoarthritis of the knee joint. Br. J. Rheum. 34:1995;306-310.
38. Shen Z., Heinegård D., Sommarin Y. Distribution and expression of cartilage oligomeric matrix protein and bone sialoprotein show marked changes during femoral head development. Matrix Biol. 14:1994;773-781.
39. Smith R.K.W., Zunino L., Webbon P.M., Bee J.A., Heinegård D. Identification of cartilage oligomeric matrix protein (COMP) in equine and bovine tendon. Transactions of the 41st Annual Meeting of the Orthopaedic Research Society, Orlando, Florida. 20:1995;16.
40. Sommarin Y., Larsson T., Heinegård D. Chondrocytematrix interactions. Attachment to proteins isolated from cartilage. Exp. Cell Res. 184:1989;181-192.
41. Towbin H., Stachelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
42. Vogel K.G., Evanko S.P. Proteoglycans of fetal bovine tendon. J. Biol. Chem. 262:1987;13607-13613.
43. Vogel K.G., Heinegård D. Characterization of proteoglycans from adult bovine tendon. J. Biol. Chem. 260:1985;9298-9306.
44. Vogel K.G., Koob T.J. Structural specialization in tendons under compression. Int. Rev. Cytol. 115:1989;267-293.
45. Vogel K.G., Ördög A., Pogány G., Oláh J. Proteoglycans in the compressed region of human tibialis posterior tendon and in ligaments. J. Orthop. Res. 11:1993a;68-77.
46. Vogel K.G., Sandy J.D., Neame P.J., Robbins J.R., Pogany G.L. Tensional and compressed regions of bovine tendon contain aggrecan. Transactions of the 39th Annual Meeting of the Orthopaedic Research Society, San Francisco, California. 18:1993b;46.
47. Vogel K.G., Sandy J.D., Pogany G., Robbins J.R. Aggrecan in bovine tendon. Matrix Biol. 14:1994;171-179.
48. Volpert O.V., Tolsma S.S., Pellerin S., Feige J.-J., Chen H., Mosher D.F., Bouck N. Inhibition of angiogenesis by thrombospondin-2. Biochem. Biophys. Res. Comm. 217:1995;326-332.
49. Weideman H.R., Kunze J. Pseudoachondroplasia. 3rd ed. Dibbern H. An Atlas of Clinical Syndromes: A Visual Aid to Diagnosis for Clinicians and Practising Physicians. 1992;268-269 Wolfe Publishing Ltd. London.
50. Zaia J., Boynton R.E., McIntosh A., Marshak E.R., Olsson H., Heinegård D., Barry F.P. Post-translational modifications in cartilage oligomeric matrix protein. Characterization of the N-linked oligosaccharides by Matrix-assisted Laser Desorption Ionization Time-of Flight Mass Spectrometry. J. Biol. Chem. 272:1997;14120-14126.